Fund Holdings — GREAT POINT PARTNERS LLC

Total Portfolio Value
$331.41M
Total Bought
$38.40M
Total Sold
$233.83M
Net Transaction
-$195.43M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
ORUKA THERAPEUTICS INC(ORKA)0514,659+514,659012,6143.81%+12,614
VIRIDIAN THERAPEUTICS INC(VRDN)500,000750,000+250,0006,50517,0635.15%+10,558
NEUROGENE INC(NGNE)1,004,2911,004,291036,54642,14012.72%+5,594
UNICYCIVE THERAPEUTICS INC08,559,000+8,559,00003,4911.05%+3,491
PROMIS NEUROSCIENCES INC02,790,698+2,790,69803,4881.05%+3,488
OLEMA PHARMACEUTICALS INC(OLMA)796,8801,000,000+203,1208,62211,9403.60%+3,318
CARTESIAN THERAPEUTICS INC(RNAC)0200,000+200,00003,2240.97%+3,224
ELIEM THERAPEUTICS INC(CLYM)0248,168+248,16801,2630.38%+1,263
HELIX ACQUISITION CORP II500,000500,00005,1105,2251.58%+115
LEXICON PHARMACEUTICALS INC(LXRX)30,0000-30,000500—-50
TSCAN THERAPEUTICS INC(TCRX)940,8311,016,375+75,5445,5045,0621.53%-442
ANAPTYSBIO INC25,0000-25,0006270—-626
KALVISTA PHARMACEUTICALS INC1,338,5681,299,503-39,06515,76815,0484.54%-720
CONTEXT THERAPEUTICS INC(CNTX)7,419,3556,934,982-484,37314,87613,5934.10%-1,283
AUTOLUS THERAPEUTICS PLC(AUTL)3,441,6672,811,955-629,71211,97710,2073.08%-1,770
ZURA BIO LTD(ZURA)4,642,2413,263,672-1,378,56916,24813,2514.00%-2,997
JASPER THERAPEUTICS INC(JSPR)402,015322,380-79,6359,1266,0641.83%-3,062
SPYRE THERAPEUTICS INC(SYRE)134,6120-134,6123,1650—-3,165
VISTAGEN THERAPEUTICS INC(VTGN)1,529,338674,075-855,2635,3222,0290.61%-3,293
KYVERNA THERAPEUTICS INC(KYTX)499,1520-499,1523,7440—-3,744
PUMA BIOTECHNOLOGY INC(PBYI)1,486,5440-1,486,5444,8460—-4,846
IONIS PHARMACEUTICALS INC(IONS)330,000255,000-75,00015,72810,2153.08%-5,512
OUTLOOK THERAPEUTICS INC(OTLK)1,701,5101,293,028-408,48212,5576,9052.08%-5,652
OPTINOSE INC13,727,09712,861,136-865,96114,2768,6172.60%-5,659
PLIANT THERAPEUTICS INC(PLRX)2,636,8641,910,121-726,74328,34621,4126.46%-6,934
VOYAGER THERAPEUTICS INC(VYGR)1,601,527959,953-641,57412,6685,6161.69%-7,052
EVOLUS INC(EOLS)2,451,7721,170,000-1,281,77226,60218,9545.72%-7,648
TERNS PHARMACEUTICALS INC1,149,4060-1,149,4067,8270—-7,827
ABIVAX SA(ABVX)2,472,1882,128,773-343,41532,68224,5237.40%-8,159
CYTOKINETICS INC(CYTK)474,202316,000-158,20225,69216,6855.03%-9,007
DYNAVAX TECHNOLOGIES CORP2,374,0001,326,234-1,047,76626,66014,7744.46%-11,886
DIANTHUS THERAPEUTICS INC(DNTH)757,929275,000-482,92919,6157,5302.27%-12,086
ESPERION THERAPEUTICS INC NE5,791,5940-5,791,59412,8570—-12,857
AMICUS THERAPEUTICS INC
COM
1,495,5000-1,495,50014,8350—-14,835
INSMED INC(INSM)250,0000-250,00016,7500—-16,750
MERUS N V523,288250,000-273,28830,96312,4903.77%-18,473
ARCELLX INC
COMMON STOCK
492,000100,000-392,00027,1538,3512.52%-18,802
UROGEN PHARMA LTD(URGN)2,906,259758,786-2,147,47348,7679,6372.91%-39,130
Page 1 of 1
GREAT POINT PARTNERS LLC — 13F Holdings — Q3 2024 | TickerTrail